Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,087
NCT00612768
Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2008
Completion: Oct 31, 2009
NCT00640250
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
Start: Apr 30, 2008
Completion: Sep 30, 2009
NCT00640614
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Phase: Phase 3
NCT00795951
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
Phase: Phase 4
Start: Nov 30, 2008
Completion: Nov 30, 2009
NCT01798589
Bioequivalence of Ethylenediamine Dihydrochloride Study
Start: Jul 31, 2012
Completion: Aug 31, 2012
NCT01797562
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Phase: N/A
Start: Dec 10, 2012
Completion: Sep 8, 2015
NCT01518348
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
Start: Dec 31, 2012
Completion: Dec 31, 2013
NCT02028182
Clinical Evaluation of Lyral® Dose Response Study
Start: Feb 28, 2013
Completion: Jun 30, 2013
NCT02028208
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
Start: Nov 4, 2013
Completion: May 24, 2016
NCT02615249
Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Start: Dec 5, 2016
Completion: Jul 15, 2019
NCT04456777
Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
Phase: Early Phase 1
Start: Jul 1, 2020
Completion: Jul 1, 2022
NCT04500834
Metal Panel Allergen Patch Test Study
Start: Feb 7, 2022
Completion: Mar 31, 2025